Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Study Identifies Biomarker Linked to… >
Study Identifies Biomarker Linked to Poor Outcomes in Pregnant Lupus Patients

Published: October 28, 2013.
By Hospital for Special Surgery
http://www.hss.edu

Researchers at Hospital for Special Surgery in New York City have identified a biomarker that may predict poor pregnancy outcomes in lupus patients.

The study, titled "Angiogenic Factor Dysregulation and Risk of Adverse Pregnancy Outcome In Lupus Pregnancies" will be presented at the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting on October 27 in San Diego.

Investigators found that an imbalance of angiogenic factors, proteins required for the development of the placenta and the health of blood vessels, is associated with poor pregnancy outcomes. Increased levels of an anti-angiogenic protein called sFlt1 in pregnant lupus patients placed them at increased risk of placental insufficiency and preeclampsia, a potentially life-threatening complication. Scientists determined that higher levels of sFlt1 reduce the activity of other angiogenic proteins (placental growth factor, PIGF; vascular endothelial growth factor, VEGF) that are necessary for growth of the placenta and the mother's blood vessels.

"Pregnant women with lupus or antiphospholipid syndrome are at increased risk for adverse outcomes, particularly preeclampsia, yet identification of those destined for complications has been elusive," said Jane Salmon, MD, director of the Lupus and APS Center of Excellence at Hospital for Special Surgery and lead author of the study. "We prospectively studied patients to see if we could find a biomarker early in pregnancy that would predict a poor outcome."

The study is part of an ongoing, multi-center research initiative led by Dr. Salmon known as PROMISSE (Predictors of pRegnancy Outcome: bioMarkers In antiphospholipid antibody Syndrome and Systemic lupus Erythematosus) funded by the National Institutes of Health to identify factors that predict pregnancy complications in women with lupus and antiphospholipid syndrome.

Lupus is a chronic inflammatory disease in which the body's own immune system attacks tissues of the body and can cause complications during pregnancy. Preeclampsia, which is characterized by the onset of high blood pressure and impaired kidney function, is life-threatening to both mother and baby.

Scientists enrolled 384 pregnant women with lupus and 153 healthy pregnant controls.

Subjects were evaluated and blood was drawn monthly beginning 12 weeks into their pregnancy. Poor pregnancy outcomes were defined as preeclampsia, fetal death, neonatal death, preterm delivery before 36 weeks because of placental insufficiency, or intrauterine growth restriction (IUGR), which refers to a poor growth rate of the baby while in the womb. Levels of sFlt1 and other angiogenic proteins were measured and compared in women with lupus versus controls.

In the study, 20 percent of pregnant lupus patients developed preeclampsia or another poor outcome. Levels of sFlt1 protein, an anti-angiogenic factor, were significantly higher in patients destined for complications compared to lupus patients whose pregnancies were uncomplicated. In contrast, levels of PlGF, an angiogenic factor, were lower. Alteration in the balance of angiogenic factors was evident as early as 12 to 15 weeks into the pregnancy and persisted throughout pregnancy in women who experienced preeclampsia or another complication.

"Measurement of sFlt1 and PlGF provide a powerful tool to identify pregnant lupus patients at high risk for poor pregnancy outcomes sufficiently early to intervene," Dr. Salmon said. "Hopefully, this will facilitate trials of novel treatments to prevent these devastating complications."


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Pregnancy 
2/18/12 
Pregnancy-related Complications Predict CVD in Middle Age
By American Heart Association
If you develop pregnancy-related hypertensive disorders or diabetes, you may have an increased risk of cardiovascular disease later in life, according to research in Circulation: Journal of the American …
Women 
1/22/13 
Hypertension During Pregnancy Increases Risk of End-stage Renal Disease
By Canadian Medical Association Journal
Women with hypertensive disorders in pregnancy are at higher risk of chronic kidney disease and end-stage renal disease compared with women without the disorders, according to a study in …
Vitamins 
4/7/10 
Vitamin C And E Supplements Do Not Reduce Risk for Blood Pressure Disorders of Pregnancy
By National Institute of Child Health and Human Development
Taking vitamin C and E supplements starting in early pregnancy does not reduce the risk for the hypertensive disorders and their complications that occur during pregnancy, according to a …
Weeks 
9/4/12 
Preeclampsia Poses a Significant Long-term Health Risk According to New Research from Ben-Gurion U.
By American Associates, Ben-Gurion University of the Negev
BEER-SHEVA, ISRAEL, September 4, 2012 -- Ben-Gurion University of the Negev (BGU) researchers have determined that preeclampsia is a significant risk factor for long-term health issues, such as chronic …
Transplantation 
10/20/11 
Successful Pregnancy Possible After Kidney Transplant
By Wiley-Blackwell
A new study recently published in the American Journal of Transplantation reveals that the ability to successfully carry a pregnancy after kidney transplantation is very high, with 73.5% live …
Women 
2/13/14 
Air Pollution Increases Risk for Hypertension in Pregnant Women
By University of Florida
GAINESVILLE, Fla. — Breathing the air outside their homes may be just as toxic to pregnant women — if not more so — as breathing in cigarette smoke, increasing …
Snoring 
9/25/12 
Starting to Snore During Pregnancy Could Indicate Risk for High Blood Pressure, U-M Study Says
By University of Michigan Health System
Ann Arbor, Mich. – Women who begin snoring during pregnancy are at strong risk for high blood pressure and preeclampsia, according to research from the University of Michigan. …
Women 
7/4/12 
Study Sheds Light on Pregnancy Complications And Overturns Common Belief
By Hospital for Special Surgery
A study led by Hospital for Special Surgery researchers has demonstrated that women who have a specific type of antibody that interferes with blood vessel function are at risk …
Screening 
1/13/14 
Embargoed News: Panel at Odds over New BP Guidelines
By American College of Physicians
1. Panel at odds over newly released blood pressure guidelines Panel members explain why they voted against raising systolic blood pressure targets …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition
All contents are copyright of their owners except U.S. Government works. U.S. Government works are assumed to be in the public domain unless otherwise noted. Everything else copyright ScienceNewsline.